Showing 2131-2140 of 2494 results for "".
- Kian Capital and RF Investment Partners to Launch US VisionMed Partnershttps://modernod.com/news/kian-capital-and-rf-investment-partners-to-launch-us-visionmed-partners/2482540/Kian Capital Partners and RF Investment Partners, two private investment firms, have announced the launch of US VisionMed Partners, a management services organization (MSO). US VisionMed Partners aims to elevate optometry practices by offering a unique model focused on medically advance
- New Partnership to Boost Access to Specialist Eye Care and Related Research for Patients Across the USAhttps://modernod.com/news/new-partnership-accelerates-access-to-critical-vision-care-in-ird-trials/2482524/A new partnership will offer seamless, end-to-end solutions that will drive progress in both patient care and research outcomes in inherited retinal diseases (IRD). The collaboration between genomics and clinical trials specialist Sano Genetics, 20/20 Onsite, and concierge pa
- AAO: Home OCT Device Improves Care for AMD Patients, Reduces Costs and Burdenhttps://modernod.com/news/aao-home-oct-device-improves-care-for-amd-patients-reduces-costs-and-burden/2482499/A newly approved home-based OCT device developed by Notel Vision is allowing patients to monitor their own eye health between appointments, providing physicians with crucial data without requiring in-office visits, according to an AAO news release. A study presented today at AAO 2024 suggest
- Eye Health America and Verséa Ophthalmics Form Preferred Supply Partnershiphttps://modernod.com/news/eye-health-america-and-versea-ophthalmics-form-preferred-supply-partnership/2482496/Eye Health America (EHA) announced a preferred partnership supply agreement with Verséa Ophthalmics. Terms of the agreement were not disclosed. EHA is an ophthalmic provider offering strategic and operational support to practice groups and ambulatory surgery centers (ASCs) in the
- Haag-Streit to Host "Biometry Focus Month 2024" with Weekly Webinars in Novemberhttps://modernod.com/news/haag-streit-to-host-biometry-focus-month-2024-with-weekly-webinars-in-november/2482492/Haag-Streit has announced the return of "Biometry Focus Month 2024" in November. The event will feature a series of live webinars every Thursday from November 7 to November 28, 2024. Each session will address critical topics in biometry, offering cataract and refractive surgeons ke
- Alcon Collaborates with Eye Care Professionals to Identify and Address Unmet Needs in the Contact Lens Industryhttps://modernod.com/news/alcon-collaborates-with-eye-care-professionals-to-identify-and-address-unmet-needs-in-the-contact-lens-industry/2482485/A new Alcon program aims to identify and address current gaps in contact lens offerings by partnering with eye care professionals. With the new Alcon Innovator Program, 20 ‘innovators’ were selected to receive and offer their patients exclusive access to Alcon’s upcoming product
- CASExGLOBAL Launches First AI-Powered Site Management Organizationhttps://modernod.com/news/casexglobal-lauches-first-ai-powered-site-management-organization/2482484/The Centers for Advanced Surgical Exploration (CASExGLOBAL) announced a new partnership with Clinical AI and iOR Partners to introduce what it is calling the first AI-powered site management organization (SMO) and bring clinical trials to ophthalmic office-based surgery (OBS) centers. i
- FDA Approves Bausch + Lomb's enVista Envy Full Range of Vision IOLhttps://modernod.com/news/bausch-lomb-announces-fda-approval-of-envista-envy-full-range-of-vision-iol/2482482/Bausch + Lomb announced that the FDA has approved the enVista Envy full range of vision IOL. The new lens is built on the enVista IOL platform and is designed to offer patients a continuous range of vision while providing excellent tolerance for dysphotopsia.
- Zeiss to Showcase New Digital AI Tools and Surgical Solutions at AAOhttps://modernod.com/news/zeiss-to-showcase-new-digital-ai-tools-and-surgical-solutions-at-aao/2482479/Zeiss will unveil a range of digital enhancements and surgical solutions at the American Academy of Ophthalmology (AAO) conference, running from October 19-21, 2024, in Chicago. These innovations span cataract, corneal refractive, retina, and glaucoma workflows, offering a digitally connecte
- After Shortage, Harrow Announces Relaunch of Triesencehttps://modernod.com/news/after-shortage-harrow-announces-relaunch-of-triesence/2482468/Harrow has officially relaunched Triesence (triamcinolone acetonide injectable suspension) 40 mg/mL, a preservative-free synthetic corticosteroid. Triesence is approved by the FDA for use in visualizing tissues during vitrectomy and treating ocular inflammatory conditions that do n